Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A poorly differentiated transitional cell carcinoma characterized by the presence of malignant cells with spindle cell morphologic features.
Biomarker and diagnostic research for sarcomatoid transitional cell carcinoma has been reported in the published literature.
No clinical trials have been registered for sarcomatoid transitional cell carcinoma.
202 publications have been identified in PubMed for sarcomatoid transitional cell carcinoma. Kisho has analyzed 42 by research type. Research spans Basic Science / Preclinical (71%), Epidemiology / Natural History (10%), and Review / Meta-Analysis (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 30 | 71% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 10:24 AM UTC
Disease patterns and progression |
4 |
10% |
Research summaries | 3 | 7% |
Patient case studies | 2 | 5% |
New treatment approaches | 2 | 5% |
Testing and diagnosis research | 1 | 2% |
Peng F (2026). [PMID: 41202811](https://pubmed.ncbi.nlm.nih.gov/41202811/). *Cancer Cell*. [Basic Science / Preclinical]
Skrupskelyte G (2026). [PMID: 41781610](https://pubmed.ncbi.nlm.nih.gov/41781610/). *Nature*. [Basic Science / Preclinical]
Oh HJ (2025). [PMID: 40860188](https://pubmed.ncbi.nlm.nih.gov/40860188/). *Int J Biol Sci*. [Basic Science / Preclinical]
Kimura K (2025). [PMID: 40989881](https://pubmed.ncbi.nlm.nih.gov/40989881/). *Surg Case Rep*. [Case Report / Case Series]
May AM (2025). [PMID: 40661608](https://pubmed.ncbi.nlm.nih.gov/40661608/). *bioRxiv*. [Basic Science / Preclinical]
Lv X (2025). [PMID: 40128178](https://pubmed.ncbi.nlm.nih.gov/40128178/). *Nat Commun*. [Basic Science / Preclinical]
Li J (2025). [PMID: 39930268](https://pubmed.ncbi.nlm.nih.gov/39930268/). *EMBO J*. [Basic Science / Preclinical]
Clausen TM (2025). [PMID: 40924474](https://pubmed.ncbi.nlm.nih.gov/40924474/). *J Clin Invest*. [Basic Science / Preclinical]
Al-Maghrabi H (2025). [PMID: 40421095](https://pubmed.ncbi.nlm.nih.gov/40421095/). *Front Oncol*. [Case Report / Case Series]
Guo Q (2025). [PMID: 40764744](https://pubmed.ncbi.nlm.nih.gov/40764744/). *Commun Biol*. [Gene Therapy / Novel Therapeutics]